Your browser doesn't support javascript.
loading
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient.
Anchisi, Sandro; Wolfer, Anita; Bisig, Bettina; Missiglia, Edoardo; Tiab, Amine; Kamel, Ehab Mohamed; Michielin, Olivier; Coukos, George; Homicsko, Krisztian.
Afiliación
  • Anchisi S; Oncology, Centre Hospitalier du Valais Romand, Sion, Switzerland.
  • Wolfer A; Swiss Agency for Therapeutic Products, SwissMedic, Bern, Switzerland.
  • Bisig B; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
  • Missiglia E; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
  • Tiab A; Service of Histocytopathology, Institut Central des Hôpitaux Valaisans, Sion, Switzerland.
  • Kamel EM; Nuclear Medicine, Centre Hospitalier du Valais Romand, Sion, Switzerland.
  • Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
  • Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.
  • Homicsko K; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Cancer Biol Ther ; 24(1): 2193116, 2023 12 31.
Article en En | MEDLINE | ID: mdl-36967525
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Melanoma Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cancer Biol Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Melanoma Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cancer Biol Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Suiza